Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Reagan

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|July 3, 2019
Prevalence and Effect on Survival of Pulmonary Hypertension in MyelofibrosisMatthew Austin, Peter J Quesenberry, Corey E Ventetuolo, et al.
Journal of Thrombosis and Thrombolysis|May 23, 2023
Choice of anticoagulation in patients with low risk antiphospholipid syndromeBrianna R Bakow, Quan Phung, David Rabinovich, et al.
Case Reports in Gastroenterology|April 3, 2025
Coexisting Collagenous Sprue and Celiac Disease: A Case ReportTyler M Selig, Ayesha Siddique, John L Reagan, et al.
Thrombosis Research|May 17, 2014
Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testingJohn L Reagan, Randall R Ingham, Samir Dalia, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 24, 2013
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studiesJorge J Castillo, Randall R Ingham, John L Reagan, et al.
Blood|February 14, 2004
Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83Brigitte Sénéchal, Adam M Boruchov, John L Reagan, et al.
Leukemia Research|June 6, 2015
Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective studyJohn L Reagan, Matthew R Sullivan, Eric S Winer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responsesJianda Yuan, Jean-Baptiste Latouche, John L Reagan, et al.
Rhode Island Medical Journal (2013)|May 27, 2021
Thrombosis in COVID-19: A Narrative Review of Current Literature and Inpatient ManagementAndrew Hsu, Sarah Ohnigian, Augustus Chang, et al.
Advances in Hematology|February 8, 2012
Nonengraftment haploidentical cellular therapy for hematologic malignanciesJohn L Reagan, Loren D Fast, Eric S Winer, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Clinical Lymphoma, Myeloma & Leukemia|July 3, 2019
Prevalence and Effect on Survival of Pulmonary Hypertension in MyelofibrosisMatthew Austin, Peter J Quesenberry, Corey E Ventetuolo, et al.
Journal of Thrombosis and Thrombolysis|May 23, 2023
Choice of anticoagulation in patients with low risk antiphospholipid syndromeBrianna R Bakow, Quan Phung, David Rabinovich, et al.
Case Reports in Gastroenterology|April 3, 2025
Coexisting Collagenous Sprue and Celiac Disease: A Case ReportTyler M Selig, Ayesha Siddique, John L Reagan, et al.
Thrombosis Research|May 17, 2014
Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testingJohn L Reagan, Randall R Ingham, Samir Dalia, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 24, 2013
Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studiesJorge J Castillo, Randall R Ingham, John L Reagan, et al.
Blood|February 14, 2004
Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83Brigitte Sénéchal, Adam M Boruchov, John L Reagan, et al.
Leukemia Research|June 6, 2015
Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective studyJohn L Reagan, Matthew R Sullivan, Eric S Winer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responsesJianda Yuan, Jean-Baptiste Latouche, John L Reagan, et al.
Rhode Island Medical Journal (2013)|May 27, 2021
Thrombosis in COVID-19: A Narrative Review of Current Literature and Inpatient ManagementAndrew Hsu, Sarah Ohnigian, Augustus Chang, et al.
Advances in Hematology|February 8, 2012
Nonengraftment haploidentical cellular therapy for hematologic malignanciesJohn L Reagan, Loren D Fast, Eric S Winer, et al.
Pageof 8